Sponsor

Hospital Israelita Albert Einstein

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Hospital Israelita Albert Einstein appears in 21 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials21
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

21 shown
Prospective and Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Brazil (SCOPe).NCT06724315 · lead sponsor · 2025-01-31
RECRUITING
The Effects of Ischemic Conditioning in Individuals With Parkinson's DiseaseNCT06293118 · lead sponsor · 2026-10-01
NOT_YET_RECRUITING
Brazilian Clinical Registry of Heart TransplantationNCT06453148 · lead sponsor · 2024-08-25
NOT_YET_RECRUITING
The ELFIE-HYPERTENSIONNCT06242483 · lead sponsor · 2024-06-14
COMPLETED
Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial HypertensionNCT05920005 · lead sponsor · 2023-08-22
COMPLETED
Impact of Telehealth Education in Diabetes PatientsNCT05696015 · lead sponsor · 2023-03-02
UNKNOWN
Real World Evidence Study of Statin Use in BrazilNCT05285085 · lead sponsor · 2021-11-19
COMPLETED
Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung CancerNCT04271384 · lead sponsor · 2020-02-12
COMPLETED
Brazilian Lung Immunotherapy StudyNCT05081674 · lead sponsor · 2020-01-01
COMPLETED
Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)NCT04040634 · lead sponsor · 2019-08-08
COMPLETED
Effects of a Application (Flourish App) in Medical StudentsNCT03895190 · lead sponsor · 2019-08-06
COMPLETED
Arm-crank Exercise Training on Cardiovascular Function of Patients With Peripheral Artery DiseaseNCT03837639 · lead sponsor · 2019-06-10
UNKNOWN
Effects of a Physical Exercise and Health Education Program for Women With Breast Cancer Undergoing ChemotherapyNCT04554823 · lead sponsor · 2019-03-01
UNKNOWN
Online Spaced Education to Improve Fall Prevention by Patients With Multiple SclerosisNCT03737097 · lead sponsor · 2019-02-21
UNKNOWN
Isometric Training on Blood Pressure and on the Autonomic Modulation of Hypertensive PatientsNCT03216317 · lead sponsor · 2017-07-15
COMPLETED
Effects of Yoga Practice in Multiple Sclerosis Patients: a Multidimensional ApproachNCT03198598 · lead sponsor · 2017-06-19
ACTIVE_NOT_RECRUITING
Activity Level and Barriers to Participate of Cardiac Rehabilitation in Advanced Heart Failure PatientsNCT03385837 · lead sponsor · 2015-03-01
COMPLETED
Imaging in the Diagnosis of Parkinson's Disease and Essential TremorNCT01446939 · lead sponsor · 2012-10-01
UNKNOWN
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in BrazilNCT06231693 · collaborator · 2023-12-04
TERMINATED
ARtificial Intelligence for Gross Tumour vOlume SegmentationNCT05775068 · collaborator · 2021-07-01
UNKNOWN
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular ResponsesNCT04568161 · collaborator · 2020-08-03
COMPLETED

Drugs studied in this sponsor's trials

5 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Hospital Israelita Albert Einstein as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
alectinib1
erlotinib1
nivolumab1
pembrolizumab1
trastuzumab deruxtecan1

Sponsor roles

lead sponsor18
collaborator3
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.